NCT00542659View on ClinicalTrials.gov

Biochemical Marker to Predict the Recurrence of Atrial Fibrillation After Surgical Maze Procedure

CompletedOBSERVATIONAL
Enrollment

86

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

December 31, 2007

Study Completion Date

February 29, 2008

Conditions
Atrial Fibrillation
Trial Locations (1)

135-710

Samsung Medical Center, Seoul

All Listed Sponsors
lead

Samsung Medical Center

OTHER

NCT00542659 - Biochemical Marker to Predict the Recurrence of Atrial Fibrillation After Surgical Maze Procedure | Biotech Hunter | Biotech Hunter